Diaceutics
PLC
PDMR Shareholding/Share
Incentive Plan and Total Voting Rights
New York, Belfast and London, 3
March 2025 - Diaceutics PLC (AIM: DXRX), a leading
technology and solutions provider to the pharma and biotech
industry, has been notified that on 28
February 2025, Global Shares Trustees (UK) Limited (the "UK Trust")
and Zedra Trust Company (Guernsey) Limited, the
trustees of the Global Diaceutics plc 2020 Employee Benefit
Trust, have purchased ordinary shares of
£0.002 in the capital of the Company ("Shares") on behalf of
Susanne Munksted, Jordan Clark, Nick Roberts and Jillian Beggs
(PDMRs), in respect of their purchase of Shares pursuant to the
Company's UK and Global Share Incentive Plan ("the SIP Schemes")
for employees. These purchases will be made each
month until further notice.
In accordance with the SIP Schemes, the Company
has matched these purchases with a matched share award over an
equivalent number of Shares purchased by the employee, in the
proportion of 1:1.
As announced on 2 October 2023, application was
made to AIM for a block listing of 1,500,000 Shares to facilitate
the admission of the Shares to trading following the exercise of
options inter alia under the SIP Schemes. Therefore, the matched
share awards for the UK PDMRs, along with those for all other
participants in the UK SIP Scheme, have been settled by the Company
issuing 5,663 Shares on 28 February 2025 to the UK Trust. The Trust
will hold these Shares on behalf of participants until they vest in
accordance with the UK Scheme rules.
Following the issue of a total of 5,662 Shares
on the exercise of share options by non PDMRs on 20 February and 26
February 2025, and the issue of 5,663 shares on 28 February 2025,
Diaceutics has [84,791,452] Shares in issue. This figure may be
used by shareholders in the Company as a denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change in their interest in, the
share capital of the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Enquiries:
|
Diaceutics
PLC
|
|
|
Ryan Keeling, Chief Executive
Officer
|
Tel: +44 (0)28 9040
6500
|
|
Nick Roberts, Chief Financial
Officer
|
investorrelations@diaceutics.com
|
|
|
|
|
Canaccord
Genuity Limited (Nomad & Broker)
|
Tel: +44 (0)20 7253
8000
|
|
Simon Bridges, Andrew Potts, Harry
Rees
|
|
|
|
|
About Diaceutics
At Diaceutics we believe that every
patient should get the opportunity to receive the right test and
the right therapy to positively impact their disease outcome. We
provide the world's leading pharma and biotech companies with an
end-to-end commercialisation solution for precision medicines
through data analytics, scientific and advisory services enabled by
our platform DXRX - The Diagnostics Network ®.
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Susanne Munksted
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Precision Medicine Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Global Share Incentive Plan ("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
Price(s)
|
Volume(s)
|
|
|
145.8 p
|
98
|
|
|
|
Conditional share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
98
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Conditional share
award: 28 February 2025
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Conditional share award:
Off-Market
|
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Jordan Clark
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Data Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
145.8 p
|
103
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
103
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 28 February 2025
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Nick Roberts
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Finance Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
145.8 p
|
103
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
103
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 28 February 2025
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |
|
Notification of a Transaction pursuant to Article 19(1) of
Regulation (EU) No. 596/2014
|
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a.
|
Name
|
Jillian Beggs
|
|
2
|
Reason for notification
|
|
|
a.
|
Position/Status
|
Chief Commercial Officer
|
|
b.
|
Initial notification/
Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
Diaceutics PLC
|
|
b.
|
LEI
|
213800VEWQBB39ZB8J81
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a.
|
Description of the financial
instrument, type of instrument
Identification Code
|
Ordinary shares of
£0.002 each
ISIN:
GB00BJQTGV64
|
|
b.
|
Nature of the transaction
|
Ongoing non-discretionary purchase
of Shares matched by the grant of conditional share award over
Shares under the Diaceutics plc UK Share Incentive Plan
("SIP")
|
|
c.
|
Price(s) and volume(s)
|
|
Share purchase:
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
145.8 p
|
103
|
|
|
|
Matched share award:
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
Nil
|
103
|
|
|
|
|
e.
|
Date of the transaction
|
Share purchase and Matched Share
award: 28 February 2025
|
|
f.
|
Place of the transaction
|
Share Purchase: AIM Market of the
London Stock Exchange
Matched Share Award:
Off-Market
|
|
|
|
|
|
|
|
| |
